Fundz

Astellas Names Michael Petroutsas as Head of US Commercial

PRIVATEFeb 22, 2024

Position

Head Of United States Commercial

Company

Astellas

Michael Petroutsas
BiotechnologyHealth CareMedicalPharmaceuticalPharmaceutical Manufacturing

Description

Astellas Pharma Inc. Chief Commercial Officer Claus Zieler has named Michael Petroutsas as Head, United States Commercial, leading the Astellas Pharma US Inc. organization

Quick answer

Astellas Names Michael Petroutsas as Head of US Commercial (February 22, 2024).

Who is the new Head Of United States Commercial at Astellas?
Astellas named Michael Petroutsas Head Of United States Commercial, announced February 22, 2024.
What did Astellas announce on February 22, 2024?
Astellas Pharma Inc. Chief Commercial Officer Claus Zieler has named Michael Petroutsas as Head, United States Commercial, leading the Astellas Pharma US Inc. organization
What does Astellas do?
Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company.
Which similar companies made leadership changes around the same time?
MBrace Therapeutics (March 5, 2024), Eli Lilly and Company (February 9, 2024), Lupin (March 9, 2024) and Innovent Biologics (February 5, 2024) also announced leadership changes within 45 days of Astellas.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Astellas, and when

A new leader at Astellas brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Astellas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Astellas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Astellas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Astellas

About

Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company. Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the Americas and around the world.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Astellas changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Astellas's next move

Learn about Strategic plan

Astellas changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.